Pharma Manufacturing Market Size & Share to Surpass $863.6 Billion by 2030 | Vantage Market Research

October 10, 2023
News
1 mins read

Source: Yahoo Finance

WASHINGTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — As per Vantage Market Research, the Pharmaceutical Manufacturing Market is poised for growth due to various factors, such as the increase in demand for pharmaceutical products, advancements in technology, and a rise in cases of chronic disorders.

According to Vantage Market Research, the Global Pharmaceutical Manufacturing Market is estimated to be valued at USD 863.6 Billion by 2030 and is expected to exhibit a CAGR of 7.8% from 2023 to 2030. The global Pharmaceutical Manufacturing market grew to USD 510.5 Billion in 2022.

Pharmaceutical Manufacturing involves numerous processes, including research & development, formulation, quality control testing, packaging, and distribution. It requires specialized facilities that comply with stringent regulations & standards to ensure product safety and efficacy. Quality control and regulatory compliance levels are crucial to ensure safe and effective drug production.

Key Highlights

By Drug Development Type, the Outsource segment contributed over 54.3% of the total revenue share 2022.
By Molecule Type, the conventional drugs (small molecules) segment is expected to witness maximum market growth over the projected period.
North America led the market in 2022, contributing 42.30% of total revenue.
The Asia Pacific region is anticipated to witness a significant market growth in the forecast period.

The Pharmaceutical Manufacturing market is highly regulated, with strict quality standards and regulations to ensure drug safety and efficacy. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are essential in approving and monitoring pharmaceutical products.

Top Companies in The Global Pharmaceutical Manufacturing Market

F. Hoffmann-La Roche Ltd. (Switzerland)
Novartis AG (Switzerland)
GlaxoSmithKline PLC (UK)
Pfizer Inc. (U.S.)
Merck & Co. Inc. (U.S.)
AstraZeneca (UK)
Johnson & Johnson (U.S.)
Sanofi SA (France)
Eli Lilly and Company (U.S.)
AbbVie Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Wuxi Apptec (China)
Samsung Biologics (South Korea)
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (U.S.)
Lonza Group AG (Switzerland)
Catalent Pharma Solutions (U.S.)
Jubilant Pharmova Limited (India)

Pharmaways

Pharmaways Global Private Limited is a company established in 2022. Headed by a group of professionals with over 25 years of experience. A team of professionals who have excelled in their respective fields of Pharma, Legal & Information Technology. We have global exposure and hands-on experience of the global Pharma industry. We are in pursuit of bringing the global Pharma Industry on a platform where they can connect, collaborate and work towards mutual growth. We have taken a step into the future by innovating a technology that will help global Pharma players to empower, excel and accelerate in their business. A platform that has been developed exclusively for the Pharma fraternity. We are a New Delhi based company with overseas offices in America and the United Kingdom.